PMCTPharmaCountry
    Inicio

Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#NDA007504 ×

UPDATED
Actualizaciones regulatorias
10 sept 2026•1 min de lectura
FDA Approves ACTHAR Injectable (NDA007504)
The FDA’s NDA007504 approval for ACTHAR injectable (25 UNITS/VIAL and 40 UNITS/VIAL) by Sanofi Aventis includes multiple priority labeling supplements, though the products are listed as discontinued.